跳至主要内容
临床试验/NCT00225693
NCT00225693已完成不适用

ELUTES III - V-Flex Plus PTX Drug Eluting Coronary Stent

Cook Group Incorporated1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2003年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1
主要终点
Evaluation by IVUS of % diameter stenosis at follow up.

研究概览

简要总结

The study is intended to collect data to evaluate effectiveness and safety of drug eluting stent devices in a dose ranging assessment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient must be eligible to undergo planned treatment of a single de novo lesion in a native coronary artery.
  • Patient must be an acceptable candidate for coronary artery bypass surgery
  • Patient or legal guardian must have given informed consent
  • Patient agrees to return at one month for an office visit to assess cardiovascular status and at 6 months for an office visit to assess cardiovascular status, an IVUS examination and a diagnostic angiogram.

排除标准

  • Patient must be less than 18 years old
  • Patient has history of bleeding diathesis or coagulopathy or will refuse blood transfusions.
  • Patient is simultaneously participating in another investigative interventional cardiovascular device or drug study.
  • Patient has known hypersensitivity or contraindication to aspirin, clopidogrel, or stainless steel, or a sensitivity to contrast dye.
  • Women of child bearing potential.
  • Patient has other medical condition that any cause non-compliance with the protocol, confound the results or is associated with limited life expectancy.

结局指标

主要结局

Evaluation by IVUS of % diameter stenosis at follow up.

次要结局

  • Major adverse events
  • Target lesion revascularization

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

V-Flex Plus PTX Drug Eluting Coronary Stent | 临床试验